A Study to Evaluate the Efficacy and Safety of RAG-01 as Monotherapy and in Combination With Chemotherapy in Patients With Non-muscle Invasive Bladder Cancer (NMIBC).
Clinical trial NCT07777848 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07777848
- Sponsor
- Ractigen Therapeutics.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2029-03-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.